跳至主要内容
临床试验/EUCTR2019-000804-14-AT
EUCTR2019-000804-14-AT进行中(未招募)1 期

The effect of hyperoxia and hypoxia on fluorescence lifetime imaging ophthalmoscopy in healthy subjects - Hyperoxia and Hypoxia on FLIO

Medical University of Vienna, Department of Clinical Pharmacology0 个研究点目标入组 35 人开始时间: 2019年3月22日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Men and women aged between 18 and 35 years
  • Normal ophthalmic findings
  • Ametropia = 6 diopters
  • Normal findings in the medical history and physical examination including ECG unless the investigator considers an abnormality to be clinically irrelevant
  • Nonsmokers
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Regular use of medication, abuse of alcoholic beverages or drugs
  • Participation in a clinical trial in the 3 weeks preceding the study
  • Treatment in the previous 3 weeks with any drug (except contraceptives)
  • Symptoms of a clinically relevant illness in the 3 weeks before the first study day
  • Blood donation during the previous 3 weeks
  • History or family history of epilepsy
  • Pregnant or breast-feeding women
  • Women of childbearing potential (neither menopausal, nor hysterectomized, nor sterilized) not using effective contraception

研究者

发起方
Medical University of Vienna, Department of Clinical Pharmacology

相似试验